By in

Offtake agreement with Swiss supplier of cannabis oil for the UK manufacture of cannabidiol (CBD) products

Press Release 
15th May 2019

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Sativa Investments PLC 

Sativa Investments PLC (NEX: SATI), (or “Sativa” or the “Company” or the “Group”), the UK’s first quoted medicinal cannabis investment vehicle and now an operating Company with two fully trading UK businesses, has entered into a commercial offtake agreement with a Swiss supplier for cannabis oil for the UK manufacture of cannabidiol (CBD) products.

The offtake agreement is with Alponics SA (“Alponics”), a company founded in 2018 with operations in Vaud and Valais, Switzerland, a country where cultivation and production of CBD products has been legal since 2017. Alponics is expected to cultivate and provide high quality CBD Distillate and Isolate, beginning production this autumn. Alponics was founded by Pacific Rim Plantation Services (PACRIM), which has over 25 years of agricultural knowledge, specialising in responsible production to the highest quality of chemical-free edible oils, ensuring environmental safety and long-term sustainability.

The Alponics leadership team includes its Chief Operating Officer who has direct experience in the Cannabis industry from working with Tilray Inc., its Chief Financial Officer with 32 years of global engineering and financial expertise, along with the backing of a significant parent company in PACRIM. Alponics is supported by an expert team of specialists, dedicated to the provision of premier customer service and ensuring long term sustainable production.

Geremy Thomas, founder and Chief Executive Officer of Sativa Investments, said: “This commercial agreement with Alponics further advances our smart-sourcing strategy. We look forward to a long and mutually beneficial relationship with Alan Chaytor and his impressive team.”

Alan Chaytor, founder of PACRIM, said: “We are delighted to be supplying Sativa and look forward to working with the Company in the coming years. Our expert team, along with our past experience in delivering to some of the world’s best-known household brands, allows us to provide Sativa with the best products and outstanding customer service.”

The agreement is for the three calendar years to December 31st December 2022 with volumes of CBD Distillate and Isolate specified and involving a fixed pricing structure.

The Directors of the Company accept responsibility for the contents of this announcement.

  – Ends –